These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 9642098)
21. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
22. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells]. Zhang RP; Yun L; Peng L; Lu B; Zhou Q; Wang H; Guo YJ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):420-2, 426. PubMed ID: 16805997 [TBL] [Abstract][Full Text] [Related]
23. Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene. Loew R; Selevsek N; Fehse B; von Laer D; Baum C; Fauser A; Kuehlcke K Mol Ther; 2004 May; 9(5):738-46. PubMed ID: 15120335 [TBL] [Abstract][Full Text] [Related]
24. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage. Hanazono Y; Yu JM; Dunbar CE; Emmons RV Hum Gene Ther; 1997 Jul; 8(11):1313-9. PubMed ID: 9295126 [TBL] [Abstract][Full Text] [Related]
25. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379 [TBL] [Abstract][Full Text] [Related]
26. Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer. Candotti F; Agbaria R; Mullen CA; Touraine R; Balzarini J; Johns DG; Blaese RM Cancer Gene Ther; 2000 Apr; 7(4):574-80. PubMed ID: 10811475 [TBL] [Abstract][Full Text] [Related]
27. [Packaging and concentrating of high titer of retrovirus containing IL-4RA]. Wang GL; Liu XT; Lu JR Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep; 11(9):761-4. PubMed ID: 19755029 [TBL] [Abstract][Full Text] [Related]
28. Efficient transduction and selection of human T-lymphocytes with bicistronic Thy1/HSV1-TK retroviral vector produced by a human packaging cell line. Lemoine FM; Mesel-Lemoine M; Cherai M; Gallot G; Vié H; Leclercq V; Trébèden-Negre H; Mammès O; Boyer O; Noguiez-Hellin P; Klatzmann D J Gene Med; 2004 Apr; 6(4):374-86. PubMed ID: 15079812 [TBL] [Abstract][Full Text] [Related]
29. Production of increased titer retrovirus vectors from stable producer cell lines by superinfection and concentration. Parente MK; Wolfe JH Gene Ther; 1996 Sep; 3(9):756-60. PubMed ID: 8875222 [TBL] [Abstract][Full Text] [Related]
30. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site. Byun J; Kim JM; Robbins PD; Kim S Gene Ther; 1998 Oct; 5(10):1441-4. PubMed ID: 9930351 [TBL] [Abstract][Full Text] [Related]
31. [Construction and identification of recombinant retroviral vector and stable cell line expressing latent membrane protein 2A of Epstein-Barr virus]. Chen Y; Zhou F; Sun BC; Liu GY; Wang B; Yao K Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Nov; 25(11):1013-5. PubMed ID: 19900370 [TBL] [Abstract][Full Text] [Related]
32. Production of retroviral vectors. Miller AD Curr Protoc Hum Genet; 2001 May; Chapter 12():Unit 12.5. PubMed ID: 18428250 [TBL] [Abstract][Full Text] [Related]
33. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Feng M; Jackson WH; Goldman CK; Rancourt C; Wang M; Dusing SK; Siegal G; Curiel DT Nat Biotechnol; 1997 Sep; 15(9):866-70. PubMed ID: 9306401 [TBL] [Abstract][Full Text] [Related]
34. Characterization of transient expression system for retroviral vector production. Hotta A; Saito Y; Kyogoku K; Kawabe Y; Nishijima K; Kamihira M; Iijima S J Biosci Bioeng; 2006 Apr; 101(4):361-8. PubMed ID: 16716946 [TBL] [Abstract][Full Text] [Related]
35. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes. Guan J; Ma L; Wei L Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195 [TBL] [Abstract][Full Text] [Related]
36. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles. Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289 [TBL] [Abstract][Full Text] [Related]
37. Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors. Kuate S; Wagner R; Uberla K J Gene Med; 2002; 4(4):347-55. PubMed ID: 12124977 [TBL] [Abstract][Full Text] [Related]
38. Sub-retroviral particles as gene transfer vectors that by-pass retrovirus-receptor interaction restrictions. Janka I; Günzburg WH; Brem G; Erfle V; Salmons B Biochem Mol Biol Int; 1993 Oct; 31(2):349-57. PubMed ID: 8275023 [TBL] [Abstract][Full Text] [Related]
39. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line. Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409 [TBL] [Abstract][Full Text] [Related]
40. A stable system for the high-titer production of multiply attenuated lentiviral vectors. Klages N; Zufferey R; Trono D Mol Ther; 2000 Aug; 2(2):170-6. PubMed ID: 10947945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]